Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of September 20, 2020
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Immunotherapy trailblazer Dr. Phil Greenberg to receive E. Donnall Thomas Lecture and Prize
American Society of Hematology honors his ‘vision, creativity and scientific rigor’ in T-cell therapy research
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists
He is among 52 immunologists selected for the AAI 2019 inaugural class of fellows, including 5 Nobel laureates
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Drs. Fred Appelbaum and Phil Greenberg elected to AACR Academy
They are among 22 scientists from around the world to join the 2019 class of Fellows
Dr. Tijana Martinov named a 2019 Parker Scholar
Early-career scientist will use funding for immunotherapy research in multiple myeloma
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
Tinkering with T cells
How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
How does leukemia escape from immunotherapy?
New tech enables deep dive into mysterious results, sets stage for future improvements
Society for Immunotherapy of Cancer to honor Dr. Phil Greenberg
Immunology research leader named 2018 recipient of Richard V. Smalley, M.D., Memorial Award and Lectureship
Dr. Phil Greenberg named 2018 Leader in Health Care
Seattle Business Magazine honors cancer immunotherapy pioneer for his work on T-cell therapy
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Unleashing T cells for adoptive immunotherapy
from the Greenberg lab, Clinical Research Division
The latest in gynecological cancer research from the Pacific Northwest
Inaugural Northwest Gynecological Cancer Symposium brings together scientists studying ovarian, cervical and endometrial cancers
Good News: Fred Hutch immunotherapy expert Dr. Phil Greenberg joins Parker Institute
Celebrating faculty and staff achievements